Highlights of a workshop to discuss targeting inflammation in cystic fibrosis

Katharine H. Banner; Hugo De Jonge; Stuart Elborn; Ellena Growcott; Erich Gulbins; Mike Konstan; Rick Moss; Chris Poll; Scott H. Randell; Adriano G. Rossi; Lorraine Thomas; David Waltz

doi:10.1016/j.jcf.2008.10.002

Highlights of a workshop to discuss targeting inflammation in cystic fibrosis

Katharine H. Banner, Hugo De Jonge, Stuart Elborn, Ellena Growcott, Erich Gulbins, Mike Konstan, Rick Moss, Chris Poll, Scott H. Randell, Adriano G. Rossi, Lorraine Thomas, David Waltz

Research output: Contribution to journal › Literature review › peer-review

Abstract

A workshop to discuss anti-inflammatory approaches in the treatment of CF was held at Novartis Institutes for Biomedical Research (NIBR, Horsham, UK) in March 2008.

Key opinion leaders in the field (Hugo De Jonge, Stuart Elborn, Erich Gulbins, Mike Konstan, Rick Moss, Scott Randell and Adriano Rossi), and NIBR scientists were brought together to collectively address three main aims: (i) to identify anti-inflammatory targets in CF, (ii) to evaluate the pros and cons of targeting specific cell types and (iii) to discuss model systems to profile potential therapeutic agents.

Original language	English
Pages (from-to)	1-8
Number of pages	8
Journal	Journal of Cystic Fibrosis
Volume	8
Issue number	1
DOIs	https://doi.org/10.1016/j.jcf.2008.10.002
Publication status	Published - Jan 2009

Access to Document

10.1016/j.jcf.2008.10.002

http://www.sciencedirect.com/science/article/pii/S156919930800146X

Induction of neutrophil apoptosis and treatment of severe lung inflammation
Rossi, A. (Principal Investigator)
MRC
1/09/07 → 29/02/12
Project: Research

Cite this

@article{1a1ad5adeabf4bfe83909b8e15499a58,

title = "Highlights of a workshop to discuss targeting inflammation in cystic fibrosis",

abstract = "A workshop to discuss anti-inflammatory approaches in the treatment of CF was held at Novartis Institutes for Biomedical Research (NIBR, Horsham, UK) in March 2008.Key opinion leaders in the field (Hugo De Jonge, Stuart Elborn, Erich Gulbins, Mike Konstan, Rick Moss, Scott Randell and Adriano Rossi), and NIBR scientists were brought together to collectively address three main aims: (i) to identify anti-inflammatory targets in CF, (ii) to evaluate the pros and cons of targeting specific cell types and (iii) to discuss model systems to profile potential therapeutic agents.The highlights of the workshop are captured in this review. (c) 2008 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.",

author = "Banner, {Katharine H.} and {De Jonge}, Hugo and Stuart Elborn and Ellena Growcott and Erich Gulbins and Mike Konstan and Rick Moss and Chris Poll and Randell, {Scott H.} and Rossi, {Adriano G.} and Lorraine Thomas and David Waltz",

year = "2009",

month = jan,

doi = "10.1016/j.jcf.2008.10.002",

language = "English",

volume = "8",

pages = "1--8",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier",

number = "1",

}

TY - JOUR

T1 - Highlights of a workshop to discuss targeting inflammation in cystic fibrosis

AU - Banner, Katharine H.

AU - De Jonge, Hugo

AU - Elborn, Stuart

AU - Growcott, Ellena

AU - Gulbins, Erich

AU - Konstan, Mike

AU - Moss, Rick

AU - Poll, Chris

AU - Randell, Scott H.

AU - Rossi, Adriano G.

AU - Thomas, Lorraine

AU - Waltz, David

PY - 2009/1

Y1 - 2009/1

N2 - A workshop to discuss anti-inflammatory approaches in the treatment of CF was held at Novartis Institutes for Biomedical Research (NIBR, Horsham, UK) in March 2008.Key opinion leaders in the field (Hugo De Jonge, Stuart Elborn, Erich Gulbins, Mike Konstan, Rick Moss, Scott Randell and Adriano Rossi), and NIBR scientists were brought together to collectively address three main aims: (i) to identify anti-inflammatory targets in CF, (ii) to evaluate the pros and cons of targeting specific cell types and (iii) to discuss model systems to profile potential therapeutic agents.The highlights of the workshop are captured in this review. (c) 2008 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

AB - A workshop to discuss anti-inflammatory approaches in the treatment of CF was held at Novartis Institutes for Biomedical Research (NIBR, Horsham, UK) in March 2008.Key opinion leaders in the field (Hugo De Jonge, Stuart Elborn, Erich Gulbins, Mike Konstan, Rick Moss, Scott Randell and Adriano Rossi), and NIBR scientists were brought together to collectively address three main aims: (i) to identify anti-inflammatory targets in CF, (ii) to evaluate the pros and cons of targeting specific cell types and (iii) to discuss model systems to profile potential therapeutic agents.The highlights of the workshop are captured in this review. (c) 2008 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

U2 - 10.1016/j.jcf.2008.10.002

DO - 10.1016/j.jcf.2008.10.002

M3 - Literature review

SN - 1569-1993

VL - 8

SP - 1

EP - 8

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

IS - 1

ER -

Highlights of a workshop to discuss targeting inflammation in cystic fibrosis

Abstract

Access to Document

Fingerprint

Projects

Induction of neutrophil apoptosis and treatment of severe lung inflammation

Cite this